Familial Cancer

, Volume 13, Issue 1, pp 45–56 | Cite as

Genetic variation at 8q24, family history of cancer, and upper gastrointestinal cancers in a Chinese population

  • Heather P. Tarleton
  • Shen-Chih Chang
  • Sungshim Lani Park
  • Lin Cai
  • Baoguo Ding
  • Na He
  • Shehnaz K. Hussain
  • Qingwu Jiang
  • Li-Na Mu
  • Jianyu Rao
  • Hua Wang
  • Nai-Chieh Y. You
  • Shun-Zhang Yu
  • Jin-Kou Zhao
  • Zuo-Feng Zhang
Original Article

Abstract

Genetic variation at 8q24 is associated with prostate, bladder, breast, colorectal, thyroid, lung, ovarian, UADT, liver and stomach cancers. However, a role for variation at 8q24 in familial clustering of upper gastrointestinal cancers has not been studied. In order to explore potential inherited susceptibility, we analyzed epidemiologic data from a population-based case–control study of upper gastrointestinal cancers from Taixing, China. The study population includes 204 liver, 206 stomach, and 218 esophageal cancer cases and 415 controls. Associations between 8q24 rs1447295, rs16901979, rs6983267 and these cancers were stratified by family history of cancer. Odds ratios and 95 % confidence intervals were adjusted for potential confounders: age, sex, education, tobacco smoking, alcohol consumption, and BMI at interview. We also adjusted for hepatitis B and aflatoxin (liver cancer) and Helicobacter pylori (stomach cancer). In a dominant model, among those with a family history of cancer, rs1447295 was positively associated with liver cancer (ORadj 2.80; 95 % CI 1.15–6.80). Heterogeneity was observed (Pheterogeneity = 0.029) with rs6983267 and liver cancer, with positive association in the dominant model among those with a family history of cancer and positive association in the recessive model among those without a family history of cancer. When considered in a genetic risk score model, each additional 8q24 risk genotype increased the odds of liver cancer by two-fold among those with a family history of cancer (ORadj 2.00; 95 % CI 1.15–3.47). These findings suggest that inherited susceptibility to liver cancer may exist in the Taixing population and that variation at 8q24 might be a genetic component of that inherited susceptibility.

Keywords

Liver cancer Stomach cancer Esophageal cancer Hepatitis B 8q24 SNPs Family history of cancer 

Abbreviations

AFB1

Plasma aflatoxin B1

SNP

Single nucleotide polymorphism

GI

Gastrointestinal

H. pylori

Helicobacter pylori

OR

Odds ratio

CI

Confidence interval

ROR

Ratio of odds ratios

GWAS

Genome wide association study

BMI

Body-mass-index

LD

Linkage disequilibrium

Supplementary material

10689_2013_9673_MOESM1_ESM.doc (66 kb)
Supplementary material 1 (DOC 66 kb)

References

  1. 1.
    Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr (2001) Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 93(1):148–152. doi:10.1002/ijc.1294 PubMedCrossRefGoogle Scholar
  2. 2.
    Donato F, Gelatti U, Chiesa R, Albertini A, Bucella E, Boffetta P, Tagger A, Ribero ML, Portera G, Fasola M, Nardi G (1999) A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study. Cancer Causes Control 10(5):417–421PubMedCrossRefGoogle Scholar
  3. 3.
    Fernandez E, La Vecchia C, D’Avanzo B, Negri E, Franceschi S (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3(3):209–212PubMedGoogle Scholar
  4. 4.
    Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein A, Taylor P (2009) Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 9:269. doi:10.1186/1471-2407-9-269 PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Hassan MM, Spitz MR, Thomas MB, Curley SA, Patt YZ, Vauthey JN, Glover KY, Kaseb A, Lozano RD, El-Deeb AS, Nguyen NT, Wei SH, Chan W, Abbruzzese JL, Li D (2009) The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 50(2):334–341. doi:10.1016/j.jhep.2008.08.016 PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Shin CM, Kim N, Yang HJ, Cho SI, Lee HS, Kim JS, Jung HC, Song IS (2009) Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 44(2):e34–e39. doi:10.1097/MCG.0b013e3181a159c4 CrossRefGoogle Scholar
  7. 7.
    Yatsuya H, Toyoshima H, Tamakoshi A, Kikuchi S, Tamakoshi K, Kondo T, Mizoue T, Tokui N, Hoshiyama Y, Sakata K, Hayakawa N, Yoshimura T (2004) Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case-control study. Br J Cancer 91(5):929–934. doi:10.1038/sj.bjc.6602067 PubMedCentralPubMedGoogle Scholar
  8. 8.
    Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85PubMedCrossRefGoogle Scholar
  9. 9.
    Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Xu J, Blondal T, Kostic J, Sun J, Ghosh S, Stacey SN, Mouy M, Saemundsdottir J, Backman VM, Kristjansson K, Tres A, Partin AW, Albers-Akkers MT, Godino-Ivan Marcos J, Walsh PC, Swinkels DW, Navarrete S, Isaacs SD, Aben KK, Graif T, Cashy J, Ruiz-Echarri M, Wiley KE, Suarez BK, Witjes JA, Frigge M, Ober C, Jonsson E, Einarsson GV, Mayordomo JI, Kiemeney LA, Isaacs WB, Catalona WJ, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39(5):631–637. doi:10.1038/ng1999 PubMedCrossRefGoogle Scholar
  10. 10.
    Hu N, Goldstein AM, Albert PS, Giffen C, Tang ZZ, Ding T, Taylor PR, Emmert-Buck MR (2003) Evidence for a familial esophageal cancer susceptibility gene on chromosome 13. Cancer Epidemiol Biomarkers Prev 12(10):1112–1115PubMedGoogle Scholar
  11. 11.
    Shih WL, Yu MW, Chen PJ, Yeh SH, Lo MT, Chang HC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Hsiao CK, Yang SY, Chen CJ (2006) Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area. Oncogene 25(22):3219–3224. doi:10.1038/sj.onc.1209345 PubMedCrossRefGoogle Scholar
  12. 12.
    Guo Y, Fang J, Liu Y, Sheng HH, Zhang XY, Chai HN, Jin W, Zhang KH, Yang CQ, Gao HJ (2011) Association between polymorphism rs6983267 and gastric cancer risk in Chinese population. World J Gastroenterol 17(13):1759–1765. doi:10.3748/wjg.v17.i13.1759 PubMedCrossRefGoogle Scholar
  13. 13.
    Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH, Zhao J, Cai L, Rao JY, Heber D, Zhang ZF (2005) Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 116(6):972–983. doi:10.1002/ijc.21137 PubMedCrossRefGoogle Scholar
  14. 14.
    Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier JB, Houlston R (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984–988. doi:10.1038/ng2085 PubMedCrossRefGoogle Scholar
  15. 15.
    Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39(5):645–649. doi:10.1038/ng2022 PubMedCrossRefGoogle Scholar
  16. 16.
    Zhang X, Chen Q, He C, Mao W, Zhang L, Xu X, Zhu J, Chen B (2012) Polymorphisms on 8q24 are associated with lung cancer risk and survival in Han Chinese. PLoS ONE 7(7):e41930. doi:10.1371/journal.pone.0041930 PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O’Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100(13):962–966. doi:10.1093/jnci/djn190 PubMedCrossRefGoogle Scholar
  18. 18.
    Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38(6):652–658. doi:10.1038/ng1808 PubMedCrossRefGoogle Scholar
  19. 19.
    Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, Stanford JL, Ostrander EA (2007) Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 16(4):809–814. doi:10.1158/1055-9965.EPI-06-1049 PubMedCrossRefGoogle Scholar
  20. 20.
    Cortessis VK, Yuan JM, Van Den Berg D, Jiang X, Gago-Dominguez M, Stern MC, Castelao JE, Xiang YB, Gao YT, Pike MC, Conti DV (2010) Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T] in multiple racial/ethnic groups: results from the Los Angeles-Shanghai case-control study. Cancer Epidemiol Biomarkers Prev 19(12):3150–3156. doi:10.1158/1055-9965.EPI-10-0763 PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, Gudmundsson J, Jakobsdottir M, Bergthorsson JT, Sigurdsson A, Blondal T, Witjes JA, Vermeulen SH, Hulsbergen-van de Kaa CA, Swinkels DW, Ploeg M, Cornel EB, Vergunst H, Thorgeirsson TE, Gudbjartsson D, Gudjonsson SA, Thorleifsson G, Kristinsson KT, Mouy M, Snorradottir S, Placidi D, Campagna M, Arici C, Koppova K, Gurzau E, Rudnai P, Kellen E, Polidoro S, Guarrera S, Sacerdote C, Sanchez M, Saez B, Valdivia G, Ryk C, de Verdier P, Lindblom A, Golka K, Bishop DT, Knowles MA, Nikulasson S, Petursdottir V, Jonsson E, Geirsson G, Kristjansson B, Mayordomo JI, Steineck G, Porru S, Buntinx F, Zeegers MP, Fletcher T, Kumar R, Matullo G, Vineis P, Kiltie AE, Gulcher JR, Thorsteinsdottir U, Kong A, Rafnar T, Stefansson K (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40(11):1307–1312. doi:10.1038/ng.229 PubMedCrossRefGoogle Scholar
  22. 22.
    Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dork T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC, Beesley J, Webb PM, Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Durst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PD (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 42(10):874–879. doi:10.1038/ng.668 PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Jones AM, Howarth KM, Martin L, Gorman M, Mihai R, Moss L, Auton A, Lemon C, Mehanna H, Mohan H, Clarke SE, Wadsley J, Macias E, Coatesworth A, Beasley M, Roques T, Martin C, Ryan P, Gerrard G, Power D, Bremmer C, Tomlinson I, Carvajal-Carmona LG (2012) Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 49(3):158–163. doi:10.1136/jmedgenet-2011-100586 PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Lochhead P, Ng MT, Hold GL, Rabkin CS, Vaughan TL, Gammon MD, Risch HA, Lissowska J, Mukhopadhya I, Chow WH, El-Omar EM (2011) Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer. Eur J Cancer Prev 20(1):54–57. doi:10.1097/CEJ.0b013e328341e320 PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Middeldorp A, Jagmohan-Changur S, van Eijk R, Tops C, Devilee P, Vasen HF, Hes FJ, Houlston R, Tomlinson I, Houwing-Duistermaat JJ, Wijnen JT, Morreau H, van Wezel T (2009) Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort. Cancer Epidemiol Biomarkers Prev 18(11):3062–3067. doi:10.1158/1055-9965.EPI-09-0601 PubMedCrossRefGoogle Scholar
  26. 26.
    Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, Matyjasik J, Mierzejewski M, Medrek K, Oszutowska D, Suchy J, Gronwald J, Teodorczyk U, Huzarski T, Byrski T, Jakubowska A, Gorski B, van de Wetering T, Walczak S, Narod SA, Lubinski J, Cybulski C (2008) A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 68(23):9982–9986. doi:10.1158/0008-5472.CAN-08-1838 PubMedCrossRefGoogle Scholar
  27. 27.
    Lu H, Cai L, Mu LN, Lu QY, Zhao J, Cui Y, Sul JH, Zhou XF, Ding BG, Elashoff RM, Marshall J, Yu SZ, Jiang QW, Zhang ZF (2006) Dietary mineral and trace element intake and squamous cell carcinoma of the esophagus in a Chinese population. Nutr Cancer 55(1):63–70. doi:10.1207/s15327914nc5501_8 PubMedCrossRefGoogle Scholar
  28. 28.
    Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, You NC, Goldstein BY, Wei GR, Chen CW, Lu QY, Zhou XF, Ding BG, Chang J, Yu SZ (2007) Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control 18(6):665–675. doi:10.1007/s10552-007-9012-x PubMedCrossRefGoogle Scholar
  29. 29.
    Chen SY, Chen CJ, Tsai WY, Ahsan H, Liu TY, Lin JT, Santella RM (2000) Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1. Nutr Cancer 38(2):179–185. doi:10.1207/S15327914NC382_6 PubMedCrossRefGoogle Scholar
  30. 30.
    Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin DP, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF (2008) Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev 17(11):3193–3202. doi:10.1158/1055-9965.EPI-08-0523 PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Haiman CA, Le Marchand L, Yamamato J, Stram DO, Sheng X, Kolonel LN, Wu AH, Reich D, Henderson BE (2007) A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39(8):954–956. doi:10.1038/ng2098 PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39(5):638–644. doi:10.1038/ng2015 PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Severi G, Hayes VM, Padilla EJ, English DR, Southey MC, Sutherland RL, Hopper JL, Giles GG (2007) The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev 16(3):610–612. doi:10.1158/1055-9965.EPI-06-0872 PubMedCrossRefGoogle Scholar
  34. 34.
    Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, Gronberg H, Duggan D, Carpten JD, Walsh PC, Xu J, Chang BL, Isaacs WB, Zheng SL (2008) Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients. Prostate 68(5):489–497. doi:10.1002/pros.20695 PubMedCrossRefGoogle Scholar
  35. 35.
    Li M, Zhou Y, Chen P, Yang H, Yuan X, Tajima K, Cao J, Wang H (2011) Genetic variants on chromosome 8q24 and colorectal neoplasia risk: a case-control study in China and a meta-analysis of the published literature. PLoS ONE 6(3):e18251. doi:10.1371/journal.pone.0018251 PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Tuupanen S, Niittymaki I, Nousiainen K, Vanharanta S, Mecklin JP, Nuorva K, Jarvinen H, Hautaniemi S, Karhu A, Aaltonen LA (2008) Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res 68(1):14–17. doi:10.1158/0008-5472.CAN-07-5766 PubMedCrossRefGoogle Scholar
  37. 37.
    Xiong F, Wu C, Bi X, Yu D, Huang L, Xu J, Zhang T, Zhai K, Chang J, Tan W, Cai J, Lin D (2010) Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population. Cancer Epidemiol Biomarkers Prev 19(7):1855–1861. doi:10.1158/1055-9965.EPI-10-0210 PubMedCrossRefGoogle Scholar
  38. 38.
    Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D’Agostino RB Sr, Cupples LA (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359(21):2208–2219. doi:10.1056/NEJMoa0804742 PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, Rayner NW, Shields B, Owen KR, Hattersley AT, Frayling TM (2006) Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 3(10):e374. doi:10.1371/journal.pmed.0030374 PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Wray NR, Goddard ME, Visscher PM (2007) Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 17(10):1520–1528. doi:10.1101/gr.6665407 PubMedCrossRefGoogle Scholar
  41. 41.
    Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA, Douglas JA (2008) Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. Int J Cancer 122(12):2876–2879. doi:10.1002/ijc.23471 PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Hamano T, Matsui H, Sekine Y, Ohtake N, Nakata S, Suzuki K (2010) Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease. J Urol 184(2):738–742. doi:10.1016/j.juro.2010.03.102 PubMedCrossRefGoogle Scholar
  43. 43.
    Wang L, McDonnell SK, Slusser JP, Hebbring SJ, Cunningham JM, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN (2007) Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 67(7):2944–2950. doi:10.1158/0008-5472.CAN-06-3186 PubMedCrossRefGoogle Scholar
  44. 44.
    Wokolorczyk D, Gliniewicz B, Stojewski M, Sikorski A, Zlowocka E, Debniak T, Jakubowska A, Gorski B, van de Wetering T, Narod SA, Lubinski J, Cybulski C (2010) The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev 19(2):167–171. doi:10.1097/CEJ.0b013e32832945c3 PubMedCrossRefGoogle Scholar
  45. 45.
    Zeegers MP, Khan HS, Schouten LJ, van Dijk BA, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Ostrer H (2011) Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variant. Eur J Hum Genet 19(1):118–120. doi:10.1038/ejhg.2010.133 PubMedCrossRefGoogle Scholar
  46. 46.
    Pemberton TJ, Mehta NU, Witonsky D, Di Rienzo A, Allayee H, Conti DV, Patel PI (2008) Prevalence of common disease-associated variants in Asian Indians. BMC Genet 9:13. doi:10.1186/1471-2156-9-13 PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, Macconaill L, Coetzee GA, Regan MM, Freedman ML (2011) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A 107(21):9742–9746. doi:10.1073/pnas.0910668107 CrossRefGoogle Scholar
  48. 48.
    Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak JR, Berman BP, Henderson BE, Frenkel B, Haiman CA, Freedman M, Tanay A, Coetzee GA (2009) Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 5(8):e1000597. doi:10.1371/journal.pgen.1000597 PubMedCentralPubMedCrossRefGoogle Scholar
  49. 49.
    Panagopoulos I, Moller E, Collin A, Mertens F (2008) The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep 20(5):1029–1033PubMedGoogle Scholar
  50. 50.
    Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM, Manak JR, Shivdasani R, Coetzee GA, Freedman ML (2009) The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41(8):882–884. doi:10.1038/ng.403 PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Bjorklund M, Wei G, Yan J, Niittymaki I, Mecklin JP, Jarvinen H, Ristimaki A, Di-Bernardo M, East P, Carvajal-Carmona L, Houlston RS, Tomlinson I, Palin K, Ukkonen E, Karhu A, Taipale J, Aaltonen LA (2009) The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41(8):885–890. doi:10.1038/ng.406 PubMedCrossRefGoogle Scholar
  52. 52.
    Wasserman NF, Aneas I, Nobrega MA (2010) An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. doi:10.1101/gr.105361.110
  53. 53.
    Sotelo J, Esposito D, Duhagon MA, Banfield K, Mehalko J, Liao H, Stephens RM, Harris TJ, Munroe DJ, Wu X (2010) Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci U S A 107(7):3001–3005. doi:10.1073/pnas.0906067107 PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Wright JB, Brown SJ, Cole MD (2010) Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 30(6):1411–1420. doi:10.1128/MCB.01384-09 PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Lamb DJ, Tannour-Louet M (2010) In vivo exploration of the functional activity of the non-coding 8q24 prostate cancer risk locus. Asian J Androl 12(6):787–789. doi:10.1038/aja.2010.102 PubMedCrossRefGoogle Scholar
  56. 56.
    Talseth-Palmer BA, Brenne IS, Ashton KA, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G, Spigelman A, Lubinski J, Scott RJ (2010) Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome. J Med Genet 48(4):279–284. doi:10.1136/jmg.2010.079962 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Heather P. Tarleton
    • 1
  • Shen-Chih Chang
    • 2
  • Sungshim Lani Park
    • 3
  • Lin Cai
    • 4
  • Baoguo Ding
    • 5
  • Na He
    • 6
  • Shehnaz K. Hussain
    • 2
    • 7
  • Qingwu Jiang
    • 6
  • Li-Na Mu
    • 8
  • Jianyu Rao
    • 2
  • Hua Wang
    • 9
  • Nai-Chieh Y. You
    • 2
  • Shun-Zhang Yu
    • 6
  • Jin-Kou Zhao
    • 10
  • Zuo-Feng Zhang
    • 2
    • 7
  1. 1.Department of Health and Human SciencesLoyola Marymount UniversityLos AngelesUSA
  2. 2.Department of Epidemiology, Fielding School of Public HealthUniversity of California, Los Angeles (UCLA)Los AngelesUSA
  3. 3.Epidemiology ProgramUniversity of Hawaii Cancer CenterHonoluluUSA
  4. 4.Department of Epidemiology, School of Public HealthFujian Medical UniversityFuzhouChina
  5. 5.Taixing City Center for Disease Control and Prevention (CDC)Taixing CityChina
  6. 6.School of Public HealthFudan UniversityShanghaiChina
  7. 7.Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles (UCLA)Los AngelesUSA
  8. 8.Department of Social and Preventive MedicineState University of New York (SUNY) at BuffaloBuffaloUSA
  9. 9.Monitoring and Evaluation UnitThe Global Fund to Fight AIDS, Tuberculosis and MalariaGenevaSwitzerland
  10. 10.Jiangsu Provincial Center for Disease Control and PreventionNanjingChina

Personalised recommendations